Pfizer CEO Albert Bourla says people are likely to need a booster dose of the vaccine six to 12 months after their first round.
From there, it will be an annual re-vaccination.
Bourla shared the news during a CVS Health live event posted to Facebook Thursday.
He also added that real-world data shows the Pfizer vaccine is effective against a worrying variant of coronavirus first seen in South Africa.
Source: CNN News Source
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
